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Originality-Significance Statement
Here  we  report  the  first  detailed  genomic  and  phenotypic  characterization  of  Saccharomyces
cerevisiae strains isolated from human intestine. This comprehensive analysis details the possible
features of gut strains enabling survival  and persistence in this complex and clinically relevant
environment. 
Microsatellite-based typing of strains revealed the existence of three main clusters and a clear
evidence of clonal expansion or colonization within the human gut.  Whole-genome sequencing
combined  with  a  plethora  of  genome-wide  analyses,  such  as  phylogenomics  on  functionally
conserved protein coding sequences, ancestry analysis, copy number variations, introgression of
non-reference  genes  and  degree  of  polymorphisms were  used.  Such  analyses  confirmed the
phylogenetic  relationships  among  strains  isolated  either  from  human  or  wasp  guts  (used  for
control) and provided functional evidence of genetic differences between strains isolated from gut
and non-gut environments. Strains were further characterized at phenotypic level to investigate
canonical features as well as cell-wall composition and host immune system recognition pattern. 
Overall, our analyses allowed us to draw relevant insights on how yeast can persist in the human
gut,  finding that  cell  wall  composition,  sporulation  efficiency and nutrient  competition  could  be
primarily involved. Interestingly, sporulation efficiency and strain ancestry were linked with strain
immunogenicity. 
This study provides evidence for selection of specific traits and gene networks in strains inhabiting
the gut, allowing us to improve our understanding on how this commensal organism establishes
symbiotic interaction with potential benefit to the host, suggesting a potential role of humans in the
evolution of this yeast.
Summary
The quest to discover the variety of ecological niches inhabited by Saccharomyces cerevisiae has
led to research in areas as diverse as wineries, oak trees, and insect guts. The discovery of fungal
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communities in the human gastrointestinal tract suggested the host’s gut as a potential reservoir
for yeast adaptation. Here we report the existence of yeast populations associated with the human
gut (HG) that differ from those isolated from other human body sites. Phylogenetic analysis on 12
microsatellite  loci  and  1,715  combined  CDSs  from  whole-genome sequencing  revealed  three
subclusters of HG strains with further evidence of clonal colonization within the host’s gut. The
presence of such subclusters was supported by other genomic features, such as copy number
variation,  absence/introgressions  of  CDSs  and  relative  polymorphism  frequency.  Functional
analysis of CDSs specific of the different subclusters suggested possible alterations in cell wall
composition  and  sporulation  features.  The  phenotypic  analysis  combined  with  immunological
profiling of these strains further showed that sporulation was related with strain-specific genomic
characteristics  in  the  immune  recognition  pattern.  We  conclude  that  both  genetic  and
environmental  factors involved in  cell  wall  remodeling  and sporulation are the main  drivers of
adaptation in S. cerevisiae populations in the human gut.
Running title: 
Human gut as Saccharomyces cerevisiae niche.
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Introduction  
Despite  in-depth  knowledge  of  the  genetic,  molecular,  and  phenotypic  traits  regulating  the
physiology  of  Saccharomyces  cerevisiae,  the  forces  shaping  its  origin  and  evolution  are  still
debated. The long lasting association of S. cerevisiae with human activities (3,150 B.C) (Cavalieri
et al., 2003; Fay and Benavides, 2005; Legras et al., 2007; Goddard et al., 2010; Liti, 2015) has led
to the idea that  its  wide use in  fermentation  has caused its  domestication.  Few studies  have
examined the population biology of  S. cerevisiae,  its  genetic  variation and evolution (Fay and
Benavides, 2005; Legras et al., 2007; Aa et al., 2006; Ezov et al., 2006; Ruderfer et al., 2006; Zhu
et al., 2016; Almeida et al., 2017; Zhu et al., 2017). However, whole genome analysis classified S.
cerevisiae strains accordingly to the isolation source (Oak, Wine/European, or West African) and
the  type  of  human  activity  from which  they  derived  (Dunn  et  al.,  2012),  suggesting  that  the
population structure of this yeast consists of a few isolated lineages and mosaicism (Liti  et al.,
2009; Liti  2015). Despite the available reports on the worldwide distribution and genetic diversity of
S. cerevisiae (Peter et al., 2018), it is still unclear how and to what extent human intervention has
shaped the baker’s yeast population structure (Liti et al., 2009; Schacherer et al., 2009; Goddard et
al., 2010; Borneman et al., 2011). Recent discovery of the role of wasps’ gut as a winter reservoir
and  potential  evolutionary  niche  for  S.  cerevisiae  indicated  how  the  ecological  cycle  of  this
microorganism is just beginning to be understood (Stefanini et al., 2012). The possible evolution of
S. cerevisiae in the gastrointestinal tract of the animals is not limited to wasps or fruit flies (Knight
et  al.,  2015),  but  probably  extends  to  vertebrates  and  finally  to  mammals.  Since  yeasts  are
ubiquitous  in  human-related  environments,  especially  in  association  with  food  production
(leavening bread and fermenting wine and beer),  it  is  not  surprising  that  yeasts,  including  S.
cerevisiae, populate the skin (Findley et al., 2013), mucosal membranes (Sobel et al., 1993; Liguori
et al., 2016), breast milk (Boix-Amorós et al., 2017), blood (Smith et al., 2002; Swinne et al., 2009),
and respiratory (Tawfik et al., 1989; Williams et al., 2007) and intestinal tracts (Ott et al., 2008;
Liguori et al.,  2016; Sokol et al.,  2017) of humans (Rizzetto et al.,  2014). Exposure to fungi is
constant, and recent studies have highlighted that the  mycobiota is a significant player in host-
 
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
4
microbe interactions, being also able to shape both innate and adaptive immunity (Hardison and
Brown, 2012; Sancho et al., 2012; Nguyen et al., 2015; Romani et al., 2015; Strati et al., 2016a).
Candida albicans is the best-known human commensal, but S. cerevisiae has also been shown to
be a potential colonizer of the human intestinal tract (Angebault et a., 2013; Xu et al., 1999; Strati
et  al.,  2016a).  A recent  hypothesis is that  human environment-associated  S. cerevisiae strains
gave rise to clinical  S. cerevisiae causing colonization/infection (Strope et al., 2015). Noticeably,
this species was identified in both immunocompromised patients (Muñoz et al., 2005.; Williams et
al., 2007; Swinne et al., 2009) and healthy subjects (Sobel et al., 1993; Smith et al., 2002).
Currently, the fungal community is emerging as a player of the symbiotic interactions in the gut
ecosystem (Ott et al., 2008; Liguori et al., 2016; Sokol et al., 2017). Studies investigating fungal
communities in chronic inflammation, especially in Inflammatory Bowel Diseases (IBD), described
a  more  heterogeneous  mycobiota  in  patients  affected  by  Crohn’s  Disease  (CD)  compared  to
healthy subjects, suggesting a role for altered mycobiota as the causative agents of inflammatory
diseases and “leaky gut” syndrome (Ott et al.,  2008; Schulze and Sonnenborn, 2009; Li et al.,
2013; Sokol et al.,  2017). An association between gut inflammation and abundance of different
yeast species, including  S. cerevisiae, was found in mouse models of chemically-induced colitis
(Iliev et al., 2012; Chiaro et al., 2017). Furthermore, Ott and collaborators showed an enrichment in
S.  cerevisiae strains  in  IBD faecal  samples  (Ott  et  al.,  2008).  A study  on  paediatric  subjects
reported  a  clear  fungal  dysbiosis  in  CD  patients  with  an  enrichment  in  Candida  spp. and  a
reduction  of  S.  cerevisiae in  disease  versus  remission,  thus  proposing  a  positive  role  of  S.
cerevisiae colonization (Sokol et al., 2017). On the other hand, Liguori and colleagues (Liguori et
al.,  2016) observed that  S. cerevisiae was enriched in the gut mucosa of CD patients, but this
yeast  species  was  also  present  in  non-inflamed  gut  mucosa.  Strikingly,  one  of  the  markers
proposed  to  discriminate  CD  from  Ulcerative  Colitis  (both  IBDs)  is  CD  positivity  for  anti-
Saccharomyces cerevisiae antibodies (ASCA) (McKenzie et al., 1990; Quinton et al., 1998; Sendid
1998).  All  these  studies  have  highlighted  the  relevance  of  S.  cerevisiae in  the  intestinal
homeostasis  and inflammation,  but  the  controversial  results  made difficult  to  have a  definitive
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answer on its role in the host health and disease. The wide genetic and phenotypic variability
observed for this yeast and the different human-associated and environmental sources could be
the causes behind the inability to draw general conclusions on the role of yeast in contributing to or
protecting from disease (Rizzetto et al., 2016).
Thus, three general questions should be resolved: (i) are there differences in terms of abundance
of strains between patients and healthy subjects?; (ii) are S. cerevisiae strains found in the human
gut genotypically and phenotypically different from non-human environments?; (iii) how related are
S. cerevisiae gut strains compared to those found on other human body sites and originated by
environment or human activities?; (iv) are there genetic features characterizing gut strains? 
In the current work, we investigated the genetic and phenotypic characteristics,  variability,  and
population structure of S. cerevisiae isolates from the human gut of paediatric patients. In addition,
to contextualize the implications of genetic variation on the ability of strains to survive and evolve in
the  harsh  intestinal  environment,  we  characterized  the  strains  for  traits  potentially  related  to
survival  or  adaptation to the gut  environment and we investigated the impact  of  the observed
genetic variations on the immunogenicity of these strains.
Results
Strain isolation, identification and typing
Aiming at the isolation of S. cerevisiae strains from human faeces, we plated faecal aliquots onto
selective media (YPD supplemented with chloramphenicol, see Experimental Procedures) allowing
the growth of only yeasts and fungi. To avoid mating of isolates after plating, faecal aliquots were
diluted to have around 10 isolates per plate. Faecal samples were collected from 34 paediatric
Crohn’s Disease (CD) patients, 27 Ulcerative Colitis (UC) patients, 1 non-IBD paediatric patient,
and 32 healthy children (HC). To identify the isolates’ species, we analysed the ITS1-5.8S-ITS2
region using Sanger sequencing and assigned the species by comparing the results with all the
ITS1-5.8S-ITS2 sequences available in the NCBI database. If the best match was a S. cerevisiae
strain, the isolate was identified as S. cerevisiae. Using this procedure, we identified a total of 35
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S. cerevisiae isolates, the great majority of which was found in CD patients, with 27 isolates from 6
different CD patients (17.7% of CD patients), 1 isolate from 1 UC (3.7%), 5 isolates from 1 non-IBD
paediatric  patient  (nIBD),  and  2  isolates  from HC (3.1%)  (see  Table  1 for  isolate  origin  and
nomenclature). However, we could not find any associations among the isolation of S. cerevisiae
strains and the type of donor, neither comparing healthy donors against patients nor considering
the different pathologies (Chi-squared test of independence p=0.523).
In order to investigate the origin of the isolated strains, we performed phylogenetic analysis based
on 12 microsatellite loci (Legras et al., 2007) (Figure 1a). Neighbor-Joining clustering based on
chord distances (Takezaki and Nei 1996) was used to assess the similarity among gut isolates and
other strains from a wide variety of sources (soil, insect gut, grape, wine fermentation, bakery and
clinical  environment),  for  a  total  of  286  strains  (Legras  et  al.,  2007).  The  inclusion  of  strains
isolated from wasp intestines was aimed at evaluating genetic similarities among strains isolated
from the gastrointestinal tract. 
Strain  clustering  was  performed through  K-means  analysis  on  chord  distances,  with  the  best
number of clusters (n=16) being identified as the smallest minimizing the distances among co-
clustering strains (Supplementary Figure 1). Strains isolated from human faeces grouped in three
clusters, with just three exceptions (the strains YB7, YB8, and YG12). A significant fraction of gut
isolates (16 out of 35),  grouped in a cluster (which we called the Human Gut 1, HG1 cluster)
together  with  five  laboratory  strains  S288C,  FY10,  W303,  fl100,  and  fl200  (Figure  1a,  beige
shading).  This  cluster  encompasses isolates (YB,  YD and YE series)  obtained from three CD
patients (B, D and E respectively, Table 1).  We identified two other sub-clusters of HG strains
(indicated in blue in Figure 1a). One group (including 1 strain from an UC patient, 2 strains from
CD patients, and 2 strains from HC), which we called HG2 (Figure 1a, pink shading) clustered
closely to strains used in bread-making (Capa1, YS4, and MUCL42920, isolated from bread and
beer).  Another group of four HG strains (called HG3, blue shading in Figure 1a), isolated from a
single  CD patient  (YH1-YH4),  co-clustered with the SK1 laboratory strain.  Interestingly,  in  two
human subclusters we also found strains that had previously been isolated from the guts of wasp
caught in the same geographical area where all patients and healthy subjects resided (Tuscany,
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Italy; Figure 1a). An additional cluster included the strains isolated from the “B” patient, YB7 and
YB8, that clustered with strains isolated from wine fermentation and grapes collected from the
Tuscany (Italy) region where that patients resided (Figure 1a). Wasp intestines were previously
shown to bear S. cerevisiae strains representing a large part of the local genetic diversity of this
species  (Stefanini  et  al.,  2012),  and  the  clustering  based  on  microsatellite  data  confirms this
observation, as wasp strains spread along the tree (Figure 1a). Some strains isolated from wasp
intestines were similar to the gut isolates, probably because of the similarity of isolation sources
(both are from intestines) and geographical location (faecal donors lived in the same region where
the wasps were caught, Tuscany, Italy). 
Noteworthy, the strains isolated from the same patient resulted more genetically similar than other
strains belonging to the same cluster (i.e. among strains of the YB, YD, YE, and YH series), as
indicated by their co-clustering (Figure 1a) and by the comparison of distances among strains
isolated from the same faecal sample and co-clustering strains (Figure 1b). In fact, strains isolated
from the same individual are more similar among each other than strains belonging to the same
cluster  (Mann-Whitney U test fdr<0.05,  Figure 1c).  To further support  the observation that  the
distance among strains isolated from the same donor was lower than the distance among strains
from other sources, we compared the genetic distances among strains isolated from the same
donor  and  among  strains  randomly  selected  from  the  dataset  of  strains  characterized  by
microsatellite analysis (10,000 sampling iterations for each group of strains isolated from the same
donor). In more than 85% of the permutations, the strains isolated from the same donor were more
similar among each other compared to re-sampled datasets (Supplementary figure 2).  These
results  suggested  either  a  clonal  expansion  of  strains  in  the  human  intestine  or  multiple
colonisations of a given faecal donor from multiple strains of the same source population.   
Strains sequencing, phylogenomics, and population analysis
To search for genetic traits characterizing HG strains, we obtained the entire genome sequence of
a selection of 18 isolates from human gut, together with a set of 4 wasps gut strains, 5 strains from
grapes, and 1 strain from wines collected in the Florence area, Italy;  Supplementary Table 1).
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Sequenced strains were selected to represent  the broadest  genetic  variability  observed in  the
microsatellite analysis (Figure 1a), by including one strain per major group and strains that did not
cluster in any major group.  As a quality control of  our study,  we sequenced a clone of S288c
progenitor, the EM93 strain, isolated from decomposing fig (Mortimer and Johnston 1986). In order
to disclose the genomic features shared by intestinal isolates, strains from wasp intestines were
selected among those that were closer to human gut isolates according to the microsatellite data
clustering (Figure 1a). In fact, by sampling a wider genetic variability of wasp strains, we would
have also included strains simply vectored by wasps (Stefanini et al., 2012) and hence not showing
features peculiar of intestinal isolates. For phylogenomic comparison purposes, we included in our
analysis  several  strains  isolated  in  previous  studies  from  various  geographical  locations  and
isolation sources, also encompassing a large number of isolates from clinical specimens (Liti et al.
2009; Strope et al., 2015). Considering that such external reference strains were sequenced as
haploids, to properly perform a phylogenetic comparison among strains, we sequenced meiotic
segregants of candidate strains from this study that were able to sporulate and give viable spores.
Other analyses (e.g.  copy number variation,  CDSs loss,  new CDSs)  were carried out  on both
meiotic segregants and parental (polyploid) strains. 
The percentage identity of reads mapped on the S288c strain genome reference ranged between
93% and 97% (Supplementary Table 2). SNP calling at high coverage (lowest=46.7, strain YP4-
40D; highest=304.7, strain YH1-28C) of newly sequenced strains with respect to the reference
genome revealed a wide variability of SNPs/indels (Single Nucleotide Polymorphisms/insertions
deletions), from a minimum of 538 total SNP/indels in the YE1 strain to a maximum of 101,330 in
the YUC22 strain (Supplementary Table 2).
SNP calling using the S288c laboratory strain’s genome as a reference was used to reconstruct
coding sequences of strains and perform per-CDS reverse multiple sequence alignment in order to
obtain  a  robust  (see  Experimental  procedures)  genome-wide  alignment  encompassing  1,715
CDSs from 144 strains, for a total of 245,990 informative loci (see Experimental procedures for
further details).  In order to fully exploit  this information, we have created a publicly accessible
database  (http://bioserver2.sbsc.unifi.it/bioinfo/yeastpop/index.html)  to  inspect  alignments  and
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produce phylogenetic trees based on concatenations of desired CDSs among the 1,715 available
CDSs.
Phylogenetic  analysis  by  approximately-maximum-likelihood  tree  construction  confirmed  the
similarity  among  groups  of  strains  isolated  from  human  faeces  observed  with  microsatellite
analysis  (Figure 2a).  STRUCTURE analysis  on genetic  variants  (Figure 2b)  assigned strains
isolated from human faeces to single clusters, indicating a common ancestor with co-clustering
strains  (Liti  et  al.,  2009;  Strope et  al.,  2015).  The  only  exception  was the YA5 strain  meiotic
segregant (YA5-46A), which could not be assigned to a specific cluster and was hence identified
as a mosaic strain, as described in Experimental Procedures (Figure 2a and b). Ancestry analysis
performed on genome-wide data after removal of strain-specific loci (keeping loci with minor allele
frequency>0.05 in the set of strains) identified seven populations that were defined as HG1, HG2,
HG3, HB (Human Body), WC (Wild Clade), sake, and Lab (Laboratory) (Figure 2b). The HG1,
HG2,  and  HG3 clusters  were  named according  to  the clustering  also  observed  by  means  of
microsatellite analysis (Figure 1a). Three of our identified clusters did not include strains isolated
from human faeces: HB (“Human Body”,  i.e.,  strains isolated from various non-gut sites of the
human  body),  WC  (“Wild  Cluster”,  i.e.,  strains  isolated  from  wild  environments  and  natural
fermentations), and the previously identified (Liti et al. 2009) sake cluster (strains used for sake
fermentation; see Figure 2). The strains isolated from donors E, B, and D were inferred to descend
from the HG1 ancestor, previously identified as Wine European (WE) (Liti et al. 2009). As observed
with microsatellite data, the strain Y13EU and the meiotic segregants of the strains YUC22, YP4,
and YA5 (YUC22-34C,  YP4-40D,  and YA5-46D respectively)  clustered together  with  the wasp
intestine strains YVPC7.6 and BIBVC5.3 descending from the same HG2 ancestor (Figure 2a and
b). The meiotic segregants of the YH1 strain (YH1-28A, YH1-28B, and YH1-28C), clustering with
the wasp intestine strain BIBVC1.1 and strains isolated from samples collected in West Africa (from
bakery,  wine,  and  other  fermentations),  were  inferred  to  descend  from  the  HG3  ancestor,
previously identified as WA (West African) (Liti et al., 2009). Interestingly, all the strains isolated
from  clinical  samples  collected  from  patients  in  Italian  hospitals  (YJM969,  YJM975,  YJM978,
YJM981, YJM984, YJM987, YJM990, YJM993, YJM996 by Strope et al.,  2015) grouped in the
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HG1 cluster, together with some of the strains isolated from human faeces in this study (YB7, YB8,
YB10, YD1, YE2, and YE3, Supplementary table 1 and in pink in Figure 2a). On the contrary, the
remaining  clinical  strains,  isolated  from  hospital  located  in  other  countries  (Portugal,  United
Kingdom-Newcastle, Romania, California, District of Columbia, Michigan, North Carolina, Texas-
USA), clustered separately from either human faeces or wasp intestine isolates (pink labels in
Figure 2a).
Genome-wide investigations on gut strains
To further describe the genome settings of human gut strains, we performed several genome-wide
analyses (Figure 3) aimed at identifying acquisitions with respect to the reference genome S288c
(introgressed  CDSs,  Supplementary  Table  3),  chromosomal  aberrations  (through  analysis  of
coverage,  Supplementary  Figure  3  and Supplementary  Table  4),  lost/multiplied  (see  the
definition below) coding DNA sequences (CDSs) defined by CDS-based copy number variations
(CNVs,  Supplementary  Table  5),  and  defective  CDSs  -whose  coding  sequence  showed  the
insertion of a premature stop codon or to an out-of-frame indel (Supplementary Table 6).
In order to discover genes present in newly sequenced strains and missing in the reference strain
(referred to as “introgressed”), for each strain, we assembled the reads that did not map to the
S288c genome. The total 2,447 identified CDSs were translated and searched in the NCBI non-
redundant protein database with BLAST (Supplementary Table 3). In order to avoid inflating the
relevance  of  introgressions,  we  evaluated  whether  introgressed  CDSs  could  complement
(“recover”)  lost  or  defective  CDSs (found  with  the  procedure  described  below)  in  each  strain
separately. Recovered CDSs were excluded from the list of introgressed CDSs. Similarly, in the
following sections on lost and defective CDSs we refer to lists of CDSs not including recovered
genes. A total of 298 CDS-derived proteins proved to confidently derive from previously known
proteins (12.1% of 2,455 total newly assembled CDSs). Among these, 233 were derived from other
S. cerevisiae strains, 30 in other  Saccharomyces spp. and 15 in  Candida spp. (Supplementary
Table 3). Interestingly, some genes derived from other Saccharomyces spp. belonged to families
such as FLO (flocculation), HXT (hexose transporters), PAU (seripauperin), ENA (sodium-pumping
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ATPase),  THI (thiamine synthesis),  IMA (isomaltase),  PHO (cell surface glycoprotein involved in
phosphate  metabolism)  (Supplementary  Table  3).  The  clustering  of  strains  based  on
presence/absence of new genes partially reproduced the clustering observed on whole-genome
data  (Figure 3a),  the  only  exception  being  YUC22-34C,  YB7,  and  YB8 strains  that  clustered
separated from previously co-clustering strains. To investigate whether the presence of new genes
could cause gain of functions, we searched for enrichments in specific GO terms (Supplementary
Table  3).  The  results  showed  that  the  HG2  group  was  enriched  for  carbohydrate  metabolic
process, cation-transporting ATPase activity, hydrolase activity,  and flocculation (CDSs from the
FLO  family) (Supplementary Table 3).  Interestingly,  the new CDSs characteristics of the HG1
cluster were enriched in GO terms related to flocculation. In addition, the HG1 group was enriched
for NADH dehydrogenase (ubiquinone) activity and respiratory chain (Supplementary Table 3). 
Coverage analysis  carried  out  on entire  chromosomes revealed a few cases of  chromosomal
polyploidies, namely on chromosome I in the YB7, YB8, and YP4-40D strains, on chromosome IX
in the Y13EU, BIBVC5.3, and YVPC7.6 strains, and on chromosome II and the terminal portion of
chromosome XI in the YUC22 strain (Supplementary Figure 3 and Supplementary Table 4). It is
surprising to observe that the coverage of the above mentioned chromosomes, despite higher, is
not above the classic 2x threshold with respect to the rest of the genome. Although this finding
could be explained for diploid strains (e.g. YB7, YB8, Y13EU, BIBVC5.3, YVPC7.6, and YUC22),
where the given chromosome could be present in three copies and the other chromosomes in two
copies, such behaviour in the haploid strain YP4-40D remains elusive. Aiming at the identification
of genetic variants associated with and possibly causing the observed polyploidies, we explored
the sequences of genes known to be involved in chromosomal segregation, as defined by the
Gene  Ontology  classification.  We could  not  find  any  genetic  variation  specific  for  the  strains
bearing  a  polyploid  chromosome I  (Supplementary Table  4).  Contrarily,  variants  in  the  BIR1
(Ser825Pro), CDC45 (Phe362Asn, Gly366Asp, and Gln496Asn), CHL1 (Asp264Asn and Thr449A),
CHL4 (Asp264Asn  and  Thr449Ala),  CSM1 (Met178Leu),  DSN1 (Ala133Glu,  Asp377Ala,
Ser413Cys,  and  Leu477Stop),  IPL1 (Phe65Cys  and  Ile140Met),  MCM7 (Thr371Ile),  NDC10
(Leu150Thr,  Val179Lys,  Pro472Tyr,  Asp549Gln),  PLC1 (Trp178Cys  and  Pro774Ser),  RFC4
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(Asp86Gly), SHP1 (Glu67Gly), SPC105 (Val827Leu), and SPT6 (Ser6Leu) genes were specifically
associated with a polyploidy in chromosome II (Supplementary Table 4). Similarly, the polyploidy
in chromosome IX was associated with variants in the  NDC10 (Arg666Asp and Arg666Glu) and
SGO1 (Ala577Gly  and  Ala577Arg)  genes  (Supplementary  Table  4).  However,  it  has  to  be
considered that such results may be affected by the limited amount of analysed strains (e.g. only
one strain, YUC22, showed a polyploidy of chromosome II). Strikingly, the polyploidies observed in
chromosomes I and IX for strains isolated from human faeces (Supplementary Table 4) were
previously found to characterize S. cerevisiae strains used in Italian industries (Zhu et al. 2016).
For each CDS, CNV was calculated as the log2-transformed ratio of the number of reads mapping
against the CDS divided by the median coverage of the genome. Notably, the clustering based on
the CNV profiles of sequenced strains (Figure 3b) generally reproduced the clustering observed
through whole-genome sequence comparison (Figure 2), with strains being grouped according to
their  ancestry,  even if  strains  belonging to  the HG1 cluster  were further  subdivided into  sub-
clusters mainly corresponding to their source of isolation (Figure 3b). In order to gain functional
insights on CNVs, we defined two categories for each CDS: “lost” CDSs, with median coverage at
least twice lower than the median coverage of the whole genome (CNV < -1) and not found among
CDSs  identified  from  non-mapping  reads  (see  Supplementary  Figure  4  for  a  graphical
representation) and “multiplied” CDSs, with median coverage at least twice higher than the median
coverage of the whole genome (CNV > +1, possibly indicating over-representation compared to the
reference strain). A detailed report of this analysis is described in  Supplementary Table 5.  The
strains belonging to the HG1 cluster showed the highest number of cluster-specific CNVs, with 47
multiplied CDSs (7 of which were Ty elements) and 74 lost CDSs (10 of which were Ty elements).
The strains belonging to the HG3 cluster showed only two cluster-specific multiplied CDSs and 44
lost CDSs (5 of which were Ty elements). Functional enrichment analysis on the lists of multiplied
or lost CDSs specific for either HG clusters or intestinal/non-intestinal strains revealed that HG2
and intestinal strains bore a higher copy number of CDSs related to the catabolism of nitrogen
sources (e.g. allantoin), as reported in Table 2 and Supplementary Table 5. Interestingly, CDSs
multiplied in non-intestinal strains were functionally associated with GO terms related to the plasma
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membrane, while CDSs lost in intestinal strains were functionally associated with GO terms related
to the cell  wall (Table 2  and Supplementary Table 5). Concerning transposable elements, we
found a large variability among the CNVs of all the classes of Ty (Ty1, Ty2, Ty3, and Ty4) when
comparing strains belonging to the LAB, HG1, HG2, and HG3 clusters, with the sole significant
association  of  lost  Ty3  CDSs in  intestinal  compared  to  non-intestinal  strains  (Supplementary
Figure 5).
We further analysed CDSs having an out-of-frame indel or whose resulting protein after translation
contains a premature stop codon (to which we will refer as “defective CDSs”), identifying a total of
414 CDSs defective in at least one of the sequenced strains (Supplementary Table 6). A few
defective  CDSs  were  found  to  be  replaced  by  CDSs  identified  from non-mapping  reads  and
therefore were excluded from further analyses. The clustering of strains’ profiles based on the
presence of defective CDSs reproduced the clustering observed through phylogenetic analysis on
whole-genome polymorphisms (Figure 2), grouping strains according to their ancestry (Figure 3c).
The location of defective CDSs for each strain in every chromosome is reported in Supplementary
Figure 6. Similarly to what we did for CDS CNVs, we examined the defective CDSs characteristic
of the HG groups by an enrichment analysis on Gene Ontology (GO) terms (using YeastMine tools,
fdr<0.05;  Supplementary  Table  6).  HG1  and  the  sequenced  strains  sharing  the  HG1  (WE)
ancestor were characterized by the highest number of cluster-specific defective CDSs (94 CDSs,
Supplementary Table 6), enriched in the cell periphery GO term (Table 2). Among the 41 CDSs
defective specifically in the members of the HG2 cluster,  we found an oligopeptide transporter
(OPT1) and a noncatalytic subunit for phospholipid translocase (CRF1) (Supplementary Table 6).
Finally,  exploring  the  52  defective  CDSs  characterizing  the  HG3  cluster,  we  found  41  CDSs
defective in all these strains of which 7 were related to the cell membrane or wall (BSC1, ECM12,
FIT2,  FIT3,  HVG1,  MNN5, and  SUR7) and 2 were related to cations transportation (CCC2 and
MMT2). Interestingly, intestinal strains contained 258 defective CDSs, which were non-defective in
strains from other sources and enriched in gene ontologies related to metal homeostasis (Table 2).
On  the  other  hand,  the  37  CDSs  defective  in  non-intestinal  strains  only  did  not  show  any
enrichment in gene ontology terms.
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Furthermore, we measured the relative frequency of polymorphism in CDSs of sequenced strains
and the resulting matrix (Supplementary figure 7) was used in a cluster analysis (Figure 3d). We
found  a  substantial  agreement  between  the  isolates  clustering  based  on  frequency  of
polymorphism (Figure 3d) and whole-genome phylogenetic comparison (Figure 2).
Phenotyping of gut strains
Considering the relevant genetic features varying between gut strains and among strains isolated
from faecal samples and from other sources, we asked whether these differences were reflected at
the phenotypic level. Hence, we studied gut strains for differences in traits relevant for growth and
survival in the gut environment: invasiveness, resistance to several physiological temperatures and
pH,  and  sporulation  (McCusker  et  al.,  1994;  Diezmann  and  Dietrich  2009)  (Figure  4 and
Supplementary Table 7). Additionally, we evaluated whether the identified populations subtended
phenotypic differences in the S. cerevisiae isolates (Figure 4 and Supplementary Table 7). The
YH  strains,  belonging  to  HG3  cluster,  were  the  only  human  intestine  strains  able  to  form
pseudohyphae  and  resist  to  oxidative  stress  and  showed  the  highest  sporulation  rate  (>30%
asci/cell at 37°C;  Figure 4 and  Supplementary Table 7). HG1 strains (especially YD, YE, and
some YB) were unable to invade the medium and sporulate (Figure 4 and Supplementary Table
7).
While all the tested strains showed the same ability to grow at various pH values, a wider variability
was observed in the growth ability at various temperatures among the tested strains (Figure 4).
We found that the growth abilities at 4°C, 40°C, 42°C and 44°C were dependent on the intestinal
origin of the strains, with strains isolated from intestines (either human or insect) having a slightly
increased fitness at 4°C (Chi-squared test p=0.022) and a decreased fitness at 40°C (Chi-squared
test p<0.001), 42°C (Chi-squared test p<0.001) and 44°C (Chi-squared test p<0.001) compared to
strains isolated from other sources (Figure 4). Furthermore, intestinal strains (isolated from either
human faeces or insect intestines) showed a significantly lower sporulation efficiency at 28°C and
37°C than strains isolated from other sources (Mann-Whitney U test p<0.001,  Supplementary
figure 8). On the other hand, a few traits statistically differed between human and wasp intestinal
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strains: human gut isolates showed a higher fitness at 40°C (Chi-squared test p<0.001) and at
42°C (Chi-squared test p=0.001) than wasp isolates (Figure 4).
Interestingly, the gut strains’ sporulation efficiency mirrored the microsatellite-based clustering and
whole-genome  based  ancestral  lineages  (Figure  1a  and  Figure  2).  Indeed,  the  HG1  group,
deriving from the HG1 (WE) ancestor showed low sporulation rate (0% or ranging from 10% to
15%),  the HG2 group showed medium/low sporulation  rate,  and HG3 strains  (with  HG3 (WA)
ancestry) showed the highest percentage of sporulation (>30%; Supplementary Table 7).  The
sequence variation of the  RME1 gene, a negative regulator of sporulation, has been shown to
correlate with the strains’ sporulation efficiency (Gerke et al., 2009). In particular, the insertion of an
adenine in position -308 (upstream to the gene’s codon start) was found to be associated with an
increase in the strain sporulation efficiency (Deutschbauer and Davis 2005). We confirmed the
relations  between  the  adenine  insertion  and  the  sporulation  efficiency  for  our  strains
(Supplementary  Figure  9).  In  addition,  according  to  our  results,  the  clustering  of  RME1
sequences (also including an upstream region encompassing the previously  identified relevant
locus,  Supplementary Figure 9) reproduced the clustering obtained with microsatellite analysis
(Figure 1a),  and  depicted  the  same strain  grouping  identified  by  means  of  ancestry  analysis
(Figure 2).
Since genome sequencing indicated a genetic variation in cell wall and mannose genes as well as
sugar  metabolism  genes  in  HG  strains,  we  analysed  the  cell  wall  sugar  composition  (see
Experimental Procedures) of a selection of 18 strains isolated from human faeces or other sources.
HPLC analyses revealed that HG strains’ cell wall shows a significantly lower content of mannose
compared to laboratory and grape strains, a lower content of glucose compared to grape strains
(Mann-Whitney U test, fdr<0.05, Figure 5a) and a higher content of galactose compared to grape
strains  (fdr<0.01;  Figure  5a).  In  addition,  strains  isolated  from  human  faeces  show a  higher
content of glucosamine in their cell walls compared to strains isolated from all the other tested
sources (grapes, laboratory, and insect intestines; fdr<0.05; Figure 5a). Furthermore, HG1 strains
showed a higher mannose content in their wall compared to strains deriving from the laboratory
ancestor (fdr<0.05), and significantly lower amounts of galactose compared to strains deriving from
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both HG2 and laboratory ancestors (Figure 5b, fdr<0.05). 
Immunophenotyping of S. cerevisiae isolates 
As observed through analyses carried out on whole-genome sequences and confirmed by cell wall
composition analysis, human gut strains show a characteristic cell wall composition. Considering
that the sugar moieties of cell wall are the principal antigens sensed by the host immune system
during host-fungal interaction (Perez-García et al., 2011; Lewis et al., 2012; O’Meara et al., 2015),
we evaluated whether the observed differences in cell  wall composition and the genomic traits
were mirrored by the strains’ immunogenicity. Direct contact of immune cells with fungi leads to
activation  of  antigen presenting  cells  and subsequent  priming of  adequate pro-inflammatory T
helper  (Th)  response  or  regulatory  T  cells  (Treg)  response  (Romani  2011).  Previous  studies
showed  a  fungal  strain-dependent  variation  of  immune  recognition  and  consequent  immune
reactivity depending on strain features (Marakalala et al., 2013; Rizzetto et al., 2013; Smith et al.,
2014; Cavalieri et al., 2018). Hence, to characterize the immune response elicited by human gut S.
cerevisiae isolates,  peripheral  blood  mononuclear  cells  (PBMCs)  were  challenged  with  HG
isolates. Strains isolated from grapes (Sgu52 and Sgu421), natural environments (BB1533 and
BT2240) and a laboratory strain (SK1), were used as controls. The induced cytokine profiles were
determined by using the  Human Milliplex® assay (Merck-Millipore) (Supplementary Figure 10
and Figure 6a-c). We measured the pro-inflammatory cytokines IL-6, IL-1β and TNF-α, expressed
by antigen presenting cells in response to fungal antigens (Qin et al., 2016; van de Veerdonk et al.,
2017), as well as the Th response cytokines IFN-γ (Th1) and IL-17 (Th17), both known to allow
resistance towards colonization of fungi such as  Aspergillus fumigatus (van de Veerdonk et al.,
2017) and Candida albicans (Gaffen et al., 2011; Gozalbo et al., 2014) and the Th2 cytokine IL-13,
involved in allergic response (Gagliani and Huber 2017). We also measured the level of IL-10, an
anti-inflammatory cytokine involved in immune tolerance towards fungi (Roussey et al., 2016). The
in vitro assay showed strain-specific differences in the cytokine profiles triggered by the challenge
(Supplementary Figure 10 and  Figure 6a-c) and revealed the Th-polarizing cytokines IL-17A,
IFN-γ,  and  IL-10  as  the  main  factors  discriminating  HG  strains  induced-  immune  responses
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(Figure  6  and Supplementary  Figure  10).  The  variable  cytokine  profiles  induced  by  the
environmental  strains  and  human  faeces  isolates  indicates  strain-specific  rather  than  source
specific immune responses (Figure 6d and Supplementary figure 4). The Principal Component
Analysis  carried  out  on  quantified  IL-17A,  IFN-γ,  and  IL-10,  and  on  strain  sporulation  levels
reproduced the same strain grouping (Figure 6d) previously observed by comparing the strains’
whole-genome sequences (Figure 2). Non-sporulating HG1 strains (i.e. YE1, YB10, YD1) showed
a tendency towards the induction of IFN-γ-mediated responses. HG2 strains with low sporulation
efficiency  (i.e.  YA5,  YB7,  YP4 and  YUC22)  induced  high  IL-17A production  (Figure 6d).  The
opposite trend was observed for the high sporulator YH1 and SK1 strains, derived from the HG3
(WA) cluster, in which the high IFN-γ mediated-inflammatory response was counterbalanced by
high levels of the immunosuppressive cytokine IL-10 (Figure 6d). 
 Discussion
In this work we performed genome-scale and phenotypic analyses aimed at exploring the possible
features of  S. cerevisiae enabling its survival  and possible inhabit  in the human gut,  therefore
candidating it to enter the list of the much better documented natural (e.g. grape, soil, trees) or
artificial (e.g. fermentation) yeast environments.
It is known that a few fungal species, mostly Candida spp., are able of growing and colonizing the
gastrointestinal tract. On the other hand, strains from species considered like “passengers”, rather
than colonizers, such as S. cerevisiae, have been shown to impact gut ecology (Hallen-Adams and
Suhr 2017), and Ott and collaborators reported an enrichment in IBD patients’ faecal samples of S.
cerevisiae as well as other fungal species (Ott et al., 2008). Although obtained in a limited number
of donors and isolated strains, we found that S. cerevisiae is more abundant in CD patients than
healthy controls.  Microsatellite  analysis  revealed that  gut  strains  show genetic  similarities  with
foodborne  strains  (HG1 and  HG2  clusters),  but  also  with  strains  isolated  from other  sources
collected in distant geographical locations, such as West Africa (HG3 cluster). The hypothesis that
some  of  the  human  intestine  strains  are  foodborne  is  also  supported  by  the  analysis  of
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chromosome  poly-ploidies.  In  fact,  poly-ploidies  in  chromosomes  I  and  IX  were  found  to
characterize Italian industrial strains (Zhu et al. 2016), and were also found in the present study in
some of the human intestine isolates descending from the HG1 and HG2 ancestors.
Notably, strains isolated from the same donor were more similar among each other than strains
sharing the same genetic cluster or randomly sampled from the strain dataset. These indications
suggest  that  either  the  strains  isolated  from  faeces  of  the  same  patient  arose  from  clonal
expansion within the gut or that patients were colonized by clonal strains from the same source.
Either way,  the observed residence of  S. cerevisiae clonal populations only in patient intestines
may indicate that  a gut  microbial  alteration (dysbiosis)  occurring in  chronic inflammation could
admit  the  expansion  or  the  survival  of  strains  showing  particular  characteristics  (Koh  2013).
Indeed, increase of the intestinal permeability, dysbiosis or even impairment of the immune system
are all conditions previously documented as complicating the fungal-host interplay (Underhill and
Iliev 2014; Chiaro et al., 2017).  The comparison of human gut isolates with strains isolated from
wasp intestines revealed further insights on this topic. Wasp intestines isolates were previously
shown to represent the regional genetic and phenotypic variability of S. cerevisiae (Stefanini et al.,
2012;  Dapporto et al.,  2016). In the current study we report  that some wasp intestine isolates
cluster  together  with  human  gut  isolates,  indicating  either  that  humans  are  exposed  to  (and
colonized by) a limited portion of the regional  S. cerevisiae strains or that only a few strains are
able to persist/survive in the human intestine.  It  is intriguing to observe that among all  clinical
strains isolated in other studies, only those isolated from patients in Italian hospitals (Liti  et  al.
2009; Strope et al., 2015) clustered together with a few strains isolated from human faeces (in the
cluster HG1), suggesting that environmental and foodborne strains from the same geographical
region can be the source to select clinically-associated yeasts, in individuals predisposed to be
colonized by them. Conversely, human gut isolates also encompassed strains belonging to other
clusters, partially reproducing what previously observed for wasp strains (Stefanini et al., 2012).
Nevertheless, wasp strains encompass a wider genetic variability than human gut strains, again
suggesting that the latter may be subjected to selection (Stefanini et al., 2012). Prompted by the
observations  on  microsatellite  data,  we  searched  for  genetic  characteristics  eventually
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characterizing gut strains by means of whole-genome sequencing. CNV analysis revealed shared
peculiarities for strains isolated from human and insect guts, compared to strains isolated from
other sources (grapes and wine). In particular, intestinal strains showed a higher number of copies
of CDSs involved in allantoin metabolism, and a lower number of copies of CDSs related to the
vacuole function and to the cell wall compared to non-gut strains. The modulation of such function,
possibly caused by the modification of CDS numbers, may result in a physiological advantage for
strains in the intestinal environment. In fact, high allantoin levels have been reported in the body
fluids of IBD patients, resulting from the general inflammation status associated with the disease
(Schicho  et  al.,  2012).  Differently,  the  complete  profile  of  either  lost  or  new  CDSs  did  not
differentiate the strains according to the isolation source, but helped in further understanding the
genetic differences among strains isolated from faecal samples. 
Considering the relevant genetic features varying among intestinal strains and between strains
isolated from faecal samples and from other sources,  we wondered whether these differences
were reflected at the phenotypic level. The characterization of strains isolated from intestines for
phenotypes  putatively  relevant  for  microbial  survival  in  the  human  gut  revealed  that  strain
sporulation efficiency and sequence variation in a specific sporulation-associated allele of  RME1
(Gerke  et  al.,  2009)  mirrored  the strains  grouping  observed  by  comparing  the  whole-genome
sequences of intestinal strains, mostly for the HG3 cluster composed by highly sporulating strains.
This result suggests a connection between sporulation and ability of certain strains to survive in the
human  (inflamed/dysbiotic)  gut.  Furthermore,  wasp  and  human  intestine  isolates  share  an
increased fitness at 4°C, while most of them have a reduced growth rate at 40°C, 42°C and 44°C,
and a generally lower sporulation efficiency at 28°C and 37°C (absent in HG1 cluster) compared to
strains isolated from other sources. These traits specific for several intestinal strains may suggest
that S. cerevisiae is allowed to reside and grow within the intestine, provided that it maintains slow
growth and low sporulation rates. We may hypothesize these strains characterized by a moderate
division  and  sporulation  rates  may  have  higher  chances  to  persist/survive  within  the  human
intestine, in particular in presence of the complex inflammatory environment such as that observed
in CD patients (Brand 2009).  Healthy human immune cells have been shown to mount a Th1
 
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
20
inflammatory response - counterbalanced by a Treg response - against S. cerevisiae cells through
the recognition of cell wall mannans (Rizzetto et al. 2010). Conversely, lack of exposed mannans
led to the induction of a Th17 inflammatory response to spores, enriched in chitin,  a molecule
exposed in S. cerevisiae bud scars and in spore cell wall (Rizzetto et al., 2010). It is interesting that
previous metagenomics studies in CD patients (Liguori et al., 2016) showed that an enrichment in
S. cerevisiae is associated with decrease of Candida and with remission. Thus, we could speculate
that  S. cerevisiae populations colonizing the gut use the host’s immune system to fight potential
competitors,  and that this reduction in opportunistic pathogens (such as  Candida)  is benign in
pathological conditions, such as CD. 
Probably even more strikingly, human intestine isolates showed a peculiar composition of their cell
wall, bearing in particular a higher content of galactose and glucosamine compared to the strains
isolated  from all  the  other  sources.  The  cell  wall  enrichment  in  galactose  residues  has  been
associated to filamentous growth, cell-cell adhesion, flocculation in S. pombe (Tanaka et al., 1999)
and  biofilm  production  in  C.  albicans  (Cavalieri  et  al.  2018),  favouring  invasiveness,  further
indicating that gut colonization requires specific traits. Thus, the peculiar cell wall composition of
these strains appears to be a gut-specific feature and could represent a selective advantage to
survive  and  expand  in  the  host  gut. Further  and  more  specialized  studies  are  necessary  to
evaluate the role of galactose in the strains persistence in the gut. 
Concerning the strains’ immunogenicity, only strains having high sporulation efficiency or belonging
to the HG3 cluster induce a concordant immune response, triggering a mixed response (the high
level  of  pro-inflammatory  IFN-γ-mediated-Th1  response  was  counterbalanced  by  strong  IL-10
induction) potentially enabling yeasts to escape immune-surveillance. On the contrary, the other
two classes of human gut strains (non- and low-sporulating or belonging to HG1 and HG2 clusters)
triggered elusive and apparently incoherent immune responses. Overall, the observations highlight
a remarkable correlation between yeast isolates’ specific genetic make-up and immunogenicity,
suggesting alternative but convergent strategies for the colonization of the gut environment. 
Despite the results reported here should be validated in larger cohort of faecal donors and yeast
isolates, the findings indicate how, from an evolutionary perspective, the gut environment could
 
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
21
serve as  a reservoir  and evolutionary  niche for  S.  cerevisiae,  in  which genetic  makeup could
ultimately influence its immunogenicity,  highlighting the need to consider the interplay between
fungal  cell  wall  and  gut  immune  function  in  determining  yeast  population  selection.  Our
observations highlight three conditions correlating with a S. cerevisiae strain ability to survive and
persist in the human intestine:  i  - the ability to exploit the harsh environment, by metabolizing
allantoin, present at high levels in IBD patients due to the action of inflammation-associated high
radical oxygen species on uric acid (Schicho et al., 2012);  ii  - a cell wall enriched in mannose,
possibly allowing  their persistence in the pre-existent Th1-based inflammatory environment of CD
patients’ intestines through IL-10 production (Brand 2009) and iii) a moderate sporulation efficiency
and growth rate at temperatures characterizing inflamed intestines, avoiding the induction of a
Th17-driven inflammatory immune response able to kill/eradicate yeast cells (Rizzetto et al. 2010,
Reuter, et al. Curr Biol. 2007).
In  intestines  characterized by  an inflammatory  condition,  as  we observed in  CD patients,  the
residence of strains with peculiar genetic characteristics and cell wall composition could be the
result of selection and adaptation to a peculiar gut environment. In this perspective, S. cerevisiae is
Generally Recognized As Safe (GRAS), since its ability to induce trained immunity provides the
host with benefits such as improved immunity and resistance to pathogens. This could lead us to
reconsider the definition of “domestication” of S. cerevisiae, emphasizing that humans, wasps, and
possibly all food-associated insects or other animals, could have vectored  S. cerevisiae among
fermented food and beverages. Studying the evolution of the strategies used by yeast to evade
immune  surveillance  or  to  provide  a  selective  advantage  to  the  host  by  modulating  immune
responses could lead to discovery the genetic features potentially turning a friend into a foe. In this
novel  perspective,  the  combination  of  genotyping,  phenotyping,  and  immunophenotyping
approaches described in this paper is a powerful approach to describe S. cerevisiae diversity.
Experimental Procedures
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Strain isolation, identification and typing
A total of 93 paediatric subjects were enrolled at the Meyer Children’s Hospital (Florence, Italy). All
parents or caregivers of paediatric faecal donors (healthy or IBD patients) were made aware of the
nature  of  the  experiment,  and  gave  written  informed  consent  for  faecal  sample  collection,  in
accordance  with  the  sampling  protocol  approved  by  the  Ethical  Committees  of  the  Meyer
Children’s  Hospital  and the Azienda Ospedaliera Universitaria  Careggi,  Florence,  Italy  (Ref.  n.
87/10).  All  individuals  were  Caucasian  and  their  age  ranged  from  4-19  years.  Faeces  were
collected from all  paediatric subjects by physicians and caregivers who had been instructed to
collect faecal samples under sterile conditions to avoid contamination. A 1 ml faeces aliquot was
plated  onto  YPD  agar  medium  (1%  yeast  extract,  2%  peptone,  2%  D-glucose,  2%  agar)
supplemented with chloramphenicol (1 mg/ml)  to avoid bacterial  growth, and incubated for  2-3
days at 28° C. Yeast genomic DNA was extracted as previously described (Hoffman and Winston
1987). Strains were identified by sequencing the ITS1-5.8S-ITS2 region, using the ITS1 and ITS4
primers  as  previously  described  (Supplementary  Table  2)  (Sebastiani  et  al.,  2002).
Saccharomyces cerevisiae strains were identified by ITS1-5.8S-ITS2 region sequence homology
with the  S.  cerevisiae  ITS1-5.8S-ITS2 region sequences available in  the NCBI  database.  The
strains identified as Saccharomyces cerevisiae were used in following analyses and compared to
strains isolated from different sources. For strain typing, a set of 286 strains isolated from various
sources  (Supplementary  Table  1)  was  characterized  in  terms  of  allelic  variation  at  12
microsatellite loci  (Legras et  al.,  2007).  The 12 microsatellite loci  were amplified as previously
described and using the primers listed in Supplementary Table 7. The PCR amplicon sizes of the
12 loci were assessed by capillary electrophoresis. The chord distance Dc matrix was calculated
for  each strain  with  a  laboratory-made program.  The phylogenetic  tree was obtained with  the
Neighbor-joining method from the distance matrices with the Phylip Neighbor 3.67 package and
drawn up using MEGA4.0 (Tamura 2011). The tree was rooted using the midpoint method. Strain
clustering  was  investigated  by  means of  K-means analysis  on chord  distances,  with  the best
number  of  clusters being identified as the lowest  number of  clusters minimizing the distances
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among  strains  of  the  same  cluster.  Significant  differences  among  distances  between  strains
grouped according to faecal donor or clustering were evaluated by means of Mann-Whitney U test
as previously done (Novitsky et al., 1999; Gilbert et al., 2001). In addition, distances among strains
isolated from the same donor were compared with distances among an equal number of strains
randomly sampled from the set of strains characterized by means of microsatellite analysis. Strains
from healthy  subjects  (Y13EU and YN19)  and  from patient  A (YA5)  were not  included  in  the
comparison because a single strain was isolated from the corresponding faecal donor.  10,000
sampling  iterations  were  carried  out  for  each  comparison,  for  a  total  of  60,000  comparisons
(10,000 iterations  x  6  groups  of  strains  isolated  from the same faecal  donor).  P-values  were
corrected for multiple testing (false discovery rate, fdr), and differences were considered significant
if fdr<0.05. 
Genome sequencing, reads alignment and genotype calling
For whole genome sequencing purposes, strains were selected to maximize the genomic variety
inferred from microsatellite phylogeny. Strains whose genome were sequenced in this study are
listed in Supplementary Table 1.  Whole genome sequencing was performed using the Genome
Analyzer  IIx  (GAIIx)  platform  and  HiSeq2000  sequencing  instruments.  The  standard  Illumina
protocol with minor modifications was followed for the creation of short-insert paired-end libraries
(Illumina Inc., Cat. # PE-930-1001), as reported in Cavalieri et al. 2018. 
Illumina run generated 16,504,557 ± 7,966,339.6 quality paired end sequences, with a read length
average of 113.8 ± 21.4 base pairs (excluding the primer sequences). On average, we found ~16.5
million  filtered reads and 14.9 million  mapped reads.  Illumina reads were subjected to quality
control (filtering and trimming) using NGS QC Toolkit v2.3.3 (Patel and Jain 2012). Paired reads
were filtered with parameters -l 70, (cutOffReadLen4HQ) and -s 20 (cutOffQualScore), allowing the
elimination of reads with a PHRED quality score lower than 20 for more than 30% of their lengths.
Moreover, reads were trimmed at the 3' end for bases with a PHRED quality score lower than 30.
Paired reads were mapped to the reference genome (Saccharomyces cerevisiae S288c, NCBI
ID=559292) using Burrows-Wheeler Aligner (BWA 0.7.12) (Li and Durbin 2009). 
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The Genome Analysis  Toolkit  (GATK 2.1)  was used for  base quality  score recalibration,  Indel
(insertion or deletion) realignment,  duplicate removal,  and to perform SNP and Indel discovery
(McKenna  et  al.,  2010),  resulting  in  strain-specific  vcf  files.  The  coding  sequences  of  the
investigated  S.  cerevisiae strains  were  generated  using  variant  imposition  (a.k.a.  consensus
calling) in order to create uniform sets of genes for further analysis. Briefly, this technique inserted
variants  (SNPs  and  Indels)  produced  by  GATK  and  specific  for  each  strain  into  the  coding
sequences of the reference strain (Supplementary Table 2) to create accurate CDSs useful for
phylogenetic  comparison  across  strains.  Other  isolates  previously  published  and  used  in  the
comparison (listed in Supplementary Table 1) were 1) identified in the NCBI Assembly database
and their CDSs (“CDS from genomic” file type) downloaded from GenBank using NCBI Download
Assembly tool (strains genomes published by Strope and collaborators (Strope et al., 2015)) or 2)
Sanger  Institute  FTP  repository  (cere_assemblies.tgz)  for  strains  published  by  Liti  and
collaborators (Liti et al., 2009). Other strains available in NCBI Assembly were evaluated for their
degree of CDS annotation and judged not suitable for inclusion. However, we considered this set of
strains  sufficiently  broad,  in  terms  of  number  of  strains,  and  considering  their  environmental
isolation  sources  and  genetic  variability,  to  allow  an  exhaustive  comparison  of  S.  cerevisiae
populations. As a whole, the dataset of genomic sequences encompassed 29 newly sequenced
strains and 119 strains previously described: 38 from clinical samples (collected from various parts
of the human body, usually in presence of co-occurring infections) and 81 from various sources;
such strains were sequenced in previous studies: 37 from the Liti et al. study (Liti et al., 2009), 82
from the Strope et al. study (Strope et al., 2015).
For ortholog identification, fasta headers of sequences were parsed using the “gene=” tag as an
annotation key. CDSs described as unknown or not-annotated, absent from the reference strain
S288C, or pertaining to mitochondrial or plasmid DNA were excluded from further analyses. All the
sequencing  data  generated  for  this  study  are  publically  available  both  as  raw and processed
whole-genome sequences (ENA ID: ERP002541 and Array Express ID: E-SYBR-8).
Phylogenomic analysis of CDS
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The coding sequences of genes present in the genomes of the previously described 144 selected
S.  cerevisiae strains  (see  the  “Genome  sequencing,  reads  alignment  and  genotype  calling”
paragraph) were collected in gene-specific sequence files in order to produce a coherent collection
of  orthologs. The resulting 2,297 ortholog sets were individually processed by reverse multiple
sequence alignment (rMSA). Briefly, CDSs were translated, aligned with clustal-omega (Sievers
and Higgins 2014) and then codons were juxtaposed in coding sequences using protein alignment
as a guide. This allowed the creation of CDS-based ortholog specific MSAs, that were eventually
reduced in size (giving a “reduced MSA”) by removing conserved alignment columns. In order to
avoid inflating differences among strains due to aberrant alignments (usually due to frameshifting
indels in at least one strain, leading to a gap rich alignment) all orthologs whose reduced MSA was
longer than 50% or the initial MSA, were considered unreliably aligned and excluded from further
analyses.  This  procedure  allowed  us  to  evaluate  whether  CDSs  with  potentially  confounding
alignments were truly polymorphic or aberrant. In fact, while polymorphic genes are relevant to
disclose species evolution, as they produce correct alignments and maintain  bona fide a role in
selective pressure,  aberrant  mutations may not  be informative  because producing inconsistent
alignments and reasonably ignored by selective pressure due to a loss-of-function of the defective
gene.
The remaining reduced ortholog MSAs were concatenated to build a single CDS-derived “genome-
wide”  alignment,  as  previously  described  (Ramazzotti  et  al.,  2012)  involving  144  strains  and
encompassing 1,715 genes, for a total of 245,990 informative loci. This alignment was eventually
used to produce a phylogenomic tree using FastTree 2.1.10 SSE3 (Price et al., 2010) with default
parameters and for population structure analysis.
Population structure analysis
For investigations of population  structure, the previously described CDS-derived “genome-wide”
alignment was analysed by using fastStructure to assign individual strains to populations (Raj et
al., 2014). Aiming at the identification of the best number of populations (K) in our dataset, we first
binned SNPs by minor allele frequency (maf, only loci with maf > 0.05 were used for this analysis),
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then fastStructure analysis was carried out testing from 3 to 13 K values (Raj et al., 2014). The
best K was identified by using the chooseK.py script of the fastStructure software (Raj et al., 2014).
Finally, strains were assigned to a given population if  showing at least 60% ancestry from that
population. Strains assigned to the same cluster are supposed to descend from the same ancestor.
Strains with less than 60% ancestry from any of the other populations were considered mosaics.
Despite strains not assigned to a given cluster are commonly considered mosaics (e.g. (Liti et al.
2009)  and (Knight  et  al.,  2015),  we acknowledge that  they  could  potentially  belong to cluster
currently not represented among the S. cerevisiae strains included in our dataset. 
Identification and analysis of S288C introgressions
In order to discover the CDSs present in newly sequenced strains and missing in the reference
strain S288C (previously termed as introgressions), the pool of Illumina reads failing to align onto
the reference strain genome was assembled using ABySS 1.9.0 (Simpson et al., 2009), adjusting
the k-mer value so that contigs with the highest N50 were maximized. The AUGUSTUS 2.5.5 gene
finder (Stanke et al.,  2008) was then run on the resulting assembled contigs using the default
Saccharomyces cerevisiae gene model. The identified CDSs were translated and searched with
Protein-Protein BLAST 2.2.31+ against the Non-redundant RefSeq protein dataset. NCBI BLAST
was used to annotate CDSs, considering the best hit as that presenting the highest value of the
ranking  score  S  =  alignment  length/protein  length  *  identity  %,  therefore  favouring  hits  that
spanned the whole query protein. In order to avoid inflating the relevance of introgressed CDSs,
we further evaluated whether introgressed genes could complement (“recover”) lost or defective
CDSs in each strain separately. Briefly, the original S288c CDSs deemed as lost or defective in a
specific strain were searched (BLAST) against the pool of introgressed CDSs from this strain,
filtering hits using the score described above. Introgressions with a score >90 for a lost or defective
CDS were considered “recovery” events, with the effect of removing recovered CDSs from the
matrices of defective and lost CDSs described in next sections. Truly introgressed CDSs (i.e. those
not  recovering  original  genes)  were  eventually  collected  and  further  analysed  as  a
presence/absence  binary  matrix  (Supplementary  table  3)  involving  all  strains.  Complete
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hierarchical  clustering  on the binary  matrix  was  performed using the hclust  function  of  the  R
statistical package on a Jaccard's Index-based distance matrix from the R package Vegan (Dixon
2003). For the functional enrichment analysis of introgressed gene lists selected on the basis of
strain  clustering  NCBI  IDs  were  converted  in  UniProt  codes,  then  a  Fisher  Exact  Test  was
performed against a reference pan-genome (obtained by combining S288C proteins and all the
introgressed proteins,  and GO-annotated by EBI  quickGO),  with p-values adjusted for  multiple
comparisons using Benjamini-Hochberg correction.  Significantly  enriched Gene Ontology terms
were identified as having p-value<0.05.
Coverage analysis and CDS-copy number estimation
Starting from bam files created by  BWA and optimized with GATK (see above),  the samtools
software (mpileup command) was used to extract the coverage value for all reference positions in
the different strains. For each strain analysed, the median coverage of the entire genome M as well
as the median coverage of specific CDSs m (coordinates were extracted from the corresponding
gff  annotation file)  was computed.  The value  CNV =  log2(m/M)  was calculated for  each CDS,
representing the copy number variation (CNV), i.e. the excess or defect in coverage with respect to
the sequenced genome. This allowed direct comparison of  CNV within the entire set of  newly
sequenced genomes. In the text, we refer to genes having CNV lower than -1 as “lost” (i.e. their
CDS median coverage is at least twice lower than that of the rest of the genome). Recovered
CDSs  (see  details  in  paragraph  “Identification  and  analysis  of  S288C  introgressions”)  were
removed from the lists of lost CDSs. CDSs were identified as cluster- or source-specific if their
CNV was lower than -1 or higher than 1 in at least a strain of the given group and not in any strain
of the other groups (Supplementary Table S3). To graphically summarise the distribution of CNVs
along the chromosomes (and generate  Figure 3a),  the average CNV values, not  including TY
elements nor subtelomeric CDSs, along each chromosome in non-overlapping bins sized 5000bp
were calculated for strains grouped according to their clustering. Functional enrichment (i.e., Gene
Ontology enrichment on molecular function) was carried out with YeastMine (Balakrishnan et al.,
2012) on lists of CDSs grouped according to either strain clusters or isolation sources; enrichment
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significance was tested by means of hypergeometric test and corrected through Holm-Bonferroni
approach,  with  significantly  enriched  Gene  Ontology  terms  identified  as  having  p-value<0.05.
Complete hierarchical clustering on the binary matrix encompassing the CNVs for all genes and all
strains was performed using the hclust function of the R statistical package on a Jaccard's Index-
based distance matrix from the R package Vegan (Dixon 2003). 
To evaluate the presence of chromosomal aneuploidies we used, for each chromosome, the CNV
formula specified above on non-overlapping genome stretches of  5000 bp,  irrespective on the
presence of CDSs. Statistically supported polyploid chromosomes were identified by applying the
same approach adopted by Zhu and collaborators (Zhu et al., G3, 2016). Briefly, for each strain we
calculated the difference of the median coverages between every couple of chromosomes. The
significance of  this  difference was evaluated by  applying a  Mann-Whitney U-test  between the
median coverages, calculated in 5000bp bins, of the two compared chromosomes. The p-values
were then corrected for multiple testing (fdr). If the absolute value of the difference of coverage
between two chromosomes was higher than the 35% of one of the two compared chromosomes,
and the comparison had an fdr<0.05, the two chromosomes were considered as having different
ploidies. Once identified the strains showing consistent aneuploidies (e.g. a given chromosome
had a coverage significantly differing from the large majority of the chromosomes of the same
strain), we searched for associations between aneuploidies and genetic variations in genes known
to be associated with chromosomal segregation.  Aiming at  this,  we obtained the list  of  genes
annotated as belonging to the Gene Ontology “chromosomal segregation” (SGD) and identified the
genetic variants for each strain. Then, we grouped strains as presenting polyploidies or having
specific polyploid chromosome and we searched for genetic variants specific for each strain group.
Identification and analysis of defective S288C genes
The CDSs obtained by consensus calling in each strain were systematically evaluated in order to
obtain  information  about  the  presence  of  possible  detrimental  mutations  that  can  affect  the
functionality  of  encoded  proteins.  In  particular,  we  considered  as  highly  detrimental  both  the
presence  of  an  out-of-frame  indel  as  well  as  the  presence  of  premature  stop  codons.  CDS
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presenting such conditions were defined as “defective”. Recovered CDSs (see details in paragraph
“Identification and analysis  of  S288C introgressions”)  were removed from the lists of  defective
CDSs.  The list  of  remaining defective genes was further analysed as a present/absent  binary
matrix (Supplementary Table 5)  involving all  strains and S288C genes.  Complete hierarchical
clustering on the binary matrix was performed using the hclust function of the R statistical package
on  a  Jaccard's  Index-based  distance  matrix  from  the  R  package  Vegan  (Dixon  2003).  To
graphically represent the distribution of defective genes along the chromosomes, such genes were
counted along each chromosome (in window sized 5000bp) for strains grouped according to their
clustering. Functional enrichment was carried out with YeastMine (Balakrishnan et al., 2012) on
lists of CDSs, not including TY elements and subtelomeric CDSs, characteristics for either clusters
or isolation sources. Enrichment significance was tested by means of the hypergeometric test and
the resulting p-value corrected through the Holm-Bonferroni approach, with significantly enriched
Gene Ontology terms identified as having an adjusted p-value<0.05. 
Analysis of polymorphism frequency in CDS
The polymorphism frequency of  each CDS was calculated for  each whole-genome sequenced
strain from strain specific vcf files (see previous paragraphs) as the ratio of the number of SNPs in
a gene and  its  bp length  (as  in  the  S288c  reference, Supplementary Table  2).  The  relative
polymorphism frequency (RPF) estimator was designed as a functional score correlated with the
probability of  maintaining the original function of the CDS: the higher the score,  the lower the
possibility that the gene function is maintained, finally mimicking CDS deletion and affecting the
relative pathway. The complete matrix of polymorphism frequencies was investigated by complete
hierarchical clustering using chord distance as a distance metric.  
Phenotyping and immunophenotyping of S. cerevisiae strains
Each strain isolated in this study was characterized for the following phenotypes: invasiveness,
pseudohyphal formation, growth at supra optimal temperatures, sporulation rate, and pH impact on
growth, all performed as previously reported (Strati et al., 2016b). Growth was qualitatively scored,
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sporulation  efficiency  was  calculated  as  the  number  of  tetrads  on  the  total  of  counted  cells.
Differences among the qualitative phenotypes of strains grouped according to either the genetic
cluster or the isolation source (intestinal or non-intestinal) were evaluated through Chi-squared test
of independence by using the chisq.test() function of the MASS R package (Venables and Ripley
2002). Differences among quantitative phenotypes were evaluated through Mann-Whitney U test.
Additionally,  cell  wall  sugar  composition  was  assessed  through  cell  wall  extraction  and  sugar
quantification  (glucose  for  glucan  content  determination,  mannose  and  glucosamine  for  chitin
content)  by  using  high-performance  anion-exchange  chromatography  coupled  with  pulsed
electrochemical detection (HPAEC-PAD), as previously described (Cavalieri et al., 2018). Aiming at
the characterization of the immune response elicited by the human gut isolates, peripheral blood
mononuclear cells (PBMCs) were challenged with S. cerevisiae cells. PBMCs were isolated from
buffy coat obtained from 6 healthy donors (age > 18 years old) according to the protocol approved
by the Ethical Committee of the Azienda Ospedaliera Universitaria Careggi, Florence, Italy (Ref. n.
87/10).  Written informed consent was obtained for  all  the blood donors.  Blood separation, cell
culture and stimulation were performed as previously described (Cavalieri et al., 2018). Challenges
were carried out by culturing PBMCs (105 cells/ml) with or without (negative control) live yeasts (106
cells/ml) in RPMI 1640 medium supplemented with 10% heat-inactivated foetal bovine serum, 2
mM L-glutamine, at 37 °C under 5% CO2. At the time indicated below, supernatants were collected
and stored at -20°C until assayed. Cytokine detection was performed using the Human Milliplex®
assay (Merck-Millipore) according to the manufacturer’s  instructions using Luminex technology.
TNF-α, IL-1β, and IL-6, were detected in 24h supernatants; IFN-γ, IL-10, IL-13 and IL-17A in 5
days supernatants.
RME1 gene sequencing and analysis
For  each  strain  isolated  in  this  study,  the  RME1 gene  and  599  nucleotides  upstream  the
corresponding start codon were sequenced through Sanger sequencing using the RME1_FWseq
and RME1_RVseq primers listed in Supplementary Table S7. As a reference, other sequences of
this  gene were obtained from the NCBI  database or  by  extracting  the region of  interest  from
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genomic  sequences  downloaded  from public  databases  as  described  in  previous  paragraphs.
Sequences  were  aligned  using  clustalW and  the  SNP sequences  were  used  to  calculate  the
Kimura-2 parameters distances used to generate the neighbor-joining tree.
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Figure legends
Figure 1: Human gut  Saccharomyces cerevisiae strain typing.  S. cerevisiae strains isolated
from  faecal  samples  and  identified  by  means  of  ITS1-5.8S-ITS2  sequencing  were  typed  by
characterizing  12  microsatellite  loci.  a) Neighbor-joining  clustering  based  on  the  DC-chord
distances calculated on the strains’ microsatellite profiles. Shaded rectangles highlight the clusters
identified  through K-means analysis.  Italic  numbers indicate  the cluster  numbering reported in
panel b; on the right, the main clusters including strains isolated from human faeces; grey numbers
reported in correspondence of the nodes of these sub-clusters are the confidence values of the
corresponding node according to bootstrap analysis; b) Comparison of chord distances, calculated
from microsatellite profiles, among strains isolated from the same patient (B, D, E, G, H, P) or
among strains clustering with the human faeces isolates. HG1, HG2, HG3, 8, and 13 refer to the
clusters highlighted in panel a. Each grey circle represents the distance between two strains of the
given group (either cluster or faecal donor); c) Results of statistical tests carried out to evaluate the
differences in  distances among strains grouped according to either donor or  clustering.  Mann-
Whitney U test was carried out among inter-strain distances, the resulting p-values were corrected
for multiple testing (false discovery rate). Differences were considered significant when fdr<0.05.
Figure 2: Reconstruction of S. cerevisiae population phylogeny. a)  S. cerevisiae strain cluster
based on the concatenated alignments of 1,715 informative CDSs (245,990 loci), obtained from
whole  genome  sequences.  Colour  code  of  labels  indicates  the  strains  origin.  Shaded  areas
indicate the inferred ancestry, as shown in panel b; b) The  strains’ most probable ancestry inferred
by  fastStructure  analysis  performed  on  whole-genome SNPs  selected  as  having  minor  allele
frequency>0.05 (28,473 loci). The proportions of the most probable inferred ancestors for each
strain are indicated by the colours of vertical bars, as reported in the legend. The blue asterisk
indicates the YA5-46A strain,  isolated from human faeces and inferred to be a mosaic  strain.
Naming of clusters: sake - sake ancestor; WA - West Africa (as reported by Liti et al., 2009); HG -
Human Gut; Lab - laboratory strains; WC - wild cluster; HB - Human Body; WE -Wine European.
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Figure  3:  CNVs,  gene  loss  prediction,  discovery  of  new  genes,  and  polymorphism
frequencies  of  strains  belonging  to  different  clusters/ancestors.  Clustering  of  sequenced
strains  based  on: a)  gained  genes,  b)  CNV’s,  c)  defective  genes,  and  d)  polymorphism
frequencies. The colour of the strain name indicates the strain’s environmental origin, while the
branch colour indicates the cluster in which the strain was found, as reported in Figure 1 (both
colour scheme are shown in key).  e)  Survey of  copy number variations (CNVs) and defective
genes  occurring  along  the  chromosomes.  Strains  were  grouped  according  to  the  clustering
membership observed by means of ancestry analysis on genomic data. For each chromosome,
two plots were generated: the upper reporting the average value of CNVs in CDSs, calculated in
5000 bp windows for strains in the corresponding group; the lower reporting the average number of
defective CDSs calculated in 5000 bp windows in the corresponding group. 
Figure 4: Strains phenotyping. Strains isolated from various environments were characterized in
traits relevant for growth and survival in the gut environment: invasiveness, sporulation efficiency,
resistance  to  several  physiological  temperatures  and  pH.  Traits  were  quantified  by  Z-score,
calculated as described in Experimental Procedures. Strain labels are coloured according to the
isolation source (environment).
Figure  5:  Cell  wall  sugar  components  of  S.  cerevisiae strains. Galactose,  glucosamine,
glucose and mannose  amounts  (%)  detected in  the  cell  wall  of  strains  grown in  presence  of
glucose  (YPD)  as  carbon  sources.  The  analysed  strains  are  categorized  considering  (a)  the
different origins (environment), as indicated in figure, and (b) the inferred ancestors (Cluster). The
graphs provide the p-values obtained by Mann-Whitney U test, corrected for multiple testing with
the false discovery rate approach; *=fdr<0.05. 
Figure 6: Immunophenotyping of S. cerevisiae strains. a,b,c) quantified amounts of IL-10, IL-
17, and IFN-γ produced by PBMCs upon stimulation with S. cerevisiae cells; PBMCs isolated from
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healthy donors were challenged with  S. cerevisiae strains isolated from human faeces, grapes,
other natural sources, and laboratory strains for 5 days and cytokines (IFN-γ, IL-10,and IL-17A)
released  in  the  supernatants  were  quantified.  Bars  in  plots  represent  the  mean  ±  standard
deviation (error bars) of cytokine amounts from 6 healthy PBMCs donors; us: unstimulated cells. d)
Correlation among genotyping,  immunophenotyping and sporulation ability of  HG  S. cerevisiae
strains. Correspondence analysis, carried out by using  the S. cerevisiae strains as cases and T-
polarizing  cytokine  levels  produced  by  healthy  human  PBMCs  in  response  to  the  strains
(quantitative variables) and the categorized sporulation rates (high>25%, low<25%) as variables.
Pie charts indicate the ancestor lineage proportion of each whole-genome sequenced strain (as
reported in Cluster  legend and coloured as in Figure 2),  grey points represent strains with no
genomic  data.  Ancestries  were  calculated  for  isolates  or  for  meiotic  segregants.  If  meiotic
segregants deriving from the same parental strain showed different ancestries, a pie-chart was
plotted for each segregant (e.g. YA5 derivatives), otherwise a single representative pie-chart was
plotted (e.g.  YH1 derivatives).  Strains not  characterized by genome sequencing but  tested for
immunophenotyping,  were indicated with  grey  dots.  In  grey  shadows,  visual  representation  of
strain grouping inferred using PAM analysis on PCA coordinates.
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Tables 
Table 1: Isolated human gut strains. 
For  CD (Crohn’s  Disease),  UC (Ulcerative Colitis),  nIBD (non-IBD Disease),  and HC (Healthy
Children) donor classes we reported the total number of donors and the number of S. cerevisiae
strains  isolated  in  the  corresponding  class.  Strains  marked  with  an  asterisk  (*)  have  been
subjected to genome sequencing. Values in squared brackets indicate the number of sequenced
meiotic segregants. 
Donor class Donor ID Strain Label
Crohn’s Disease (CD) 
n° subjects = 34,
having S. cerevisiae = 6
A YA5* [2*]
B YB7*, YB8*, YB9, YB10*, YB11, YB12, YB13
P YP1, YP2, YP3, YP4 [1*]
D YD1*, YD2, YD3, YD4, YD5, YD6
E YE1*, YE2*, YE3*, YE4, YE5
H YH1* [3*], YH2, YH3, YH4
Ulcerative Colitis (UC) 
n° subjects = 27,
having S. cerevisiae = 1
UC22 YUC22* [1*]
non-IBD Disease (nIBD) 
n° subjects = 1
having S. cerevisiae = 1
G YG9, YG12, YG13, YG14, YG15
Healthy Children (HC) 
n° subjects = 32,
having S. cerevisiae = 2
N19 YN19
EU13 Y13EU*
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Table 2: GO terms enrichment analyses. 
Results of the GO Enrichment analysis performed on multiplied, lost, or defective CDS lists specific
of  the  different  clusters/groups  investigated  in  this  work.  For  each  GO  category,  only  terms
enriched with an fdr < 0.05 are included. 
Gene Ontology
Type Cluster  /
group
Biological Process Cellular Component Molecular Function
CNV  higher
than 1
HG1 none
integral  component  of  plasma  membrane
[GO:0005887],  intrinsic  component  of
plasma  membrane  [GO:0031226],  cell
periphery  [GO:0071944],  plasma
membrane  part  [GO:0044459],plasma
membrane [GO:0005886]
inorganic  molecular  entity
transmembrane  transporter  activity
[GO:0015318],  ion  transmembrane
transporter  activity  [GO:0015075],
transmembrane  transporter  activity
[GO:0022857]
HG2
allantoin  metabolic  process
[GO:0000255],  allantoin
catabolic  process
[GO:0000256],  cellular  amide
catabolic process [GO:0043605]
none none
HG3 none none none
intestinal
allantoin  metabolic  process
[GO:0000255],  allantoin
catabolic process [GO:0000256]
none none
non-intestinal none
cell  periphery  [GO:0071944],  integral
component  of  plasma  membrane
[GO:0005887],  intrinsic  component  of
plasma membrane [GO:0031226],  plasma
membrane  [GO:0005886],  plasma
membrane part [GO:0044459]
none
CNV  lower
than -1 (lost)
HG1 none none none
HG2 none none none
HG3 none none none
intestinal none
cell  wall  [GO:0005618],  external
encapsulating  structure  [GO:0030312],
fungal-type  cell  wall  [GO:0009277],  cell
periphery  [GO:0071944],  vacuole
[GO:0005773]
structural  constituent  of  cell  wall
[GO:0005199]
non-intestinal none none none
defective
genes
HG1 none cell periphery [GO:0071944] none
HG2 none none none
HG3 none none none
intestinal
iron  ion  homeostasis
[GO:0055072],  metal  ion
homeostasis  [GO:0055065],
cellular  iron  ion  homeostasis
[GO:0006879]
none none
non-intestinal none none none
 
1189
1190
1191
1192
1193
1194
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